Skip to content

Single center open cohort study of liver fibrosis

Single center open cohort study of liver fibrosis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500105994
Enrollment
Unknown
Registered
2025-07-15
Start date
2022-09-21
Completion date
Unknown
Last updated
2025-07-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Fibrosis

Interventions

Liver Fibrosis group:Not available

Sponsors

Taizhou Central Hospital (Taizhou University Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Imaging (CT, B-ultrasound showing fatty liver); 2. Pathological diagnosis of fatty liver in liver tissue (fatty liver disease activity score>0); 3. Overweight or obesity (BMI >= 23kg/m^2, waist circumference >= 90/80cm); 4. Obesity complicated with hypertension (blood pressure >= 130/85 mmHg), pre diabetes (glycosylated hemoglobin >= 5.7), and one or more blood biomarkers/scores (plasma triglyceride >= 1.70 mmol/L, plasma HDL cholesterol =2 mg/L);

Exclusion criteria

Exclusion criteria: 1. Age 80 years old; 2. Pregnancy; 3. Malignant tumors; 4. Serious chronic underlying diseases, such as chronic renal insufficiency (uremia phase); Chronic heart failure (grade III-IV); Taking anticoagulant drugs after coronary intervention surgery; Severe sequelae of cerebral hemorrhage or infarction (lower limb paralysis or hemiplegia, etc.); Bone marrow fibrosis and aplastic anemia; Systemic complications such as acute exacerbation of chronic obstructive pulmonary disease; 5. Received hormone and/or immunosuppressive therapy for non liver diseases in the past year, such as hormone therapy for autoimmune diseases and anti rejection drugs for organ transplantation; 6. Serious mental illnesses such as schizophrenia, depression, mania, etc; 7. Others, such as HIV, syphilis, etc.

Design outcomes

Primary

MeasureTime frame
Body mass index (BMI);Routine blood test;C-reactive protein;Insulin;Glycosylated hemoglobin (HbA1c);Coagulation function;Thyroid function test;Liver function indicators;

Countries

China

Contacts

Public ContactHassan

Taizhou Central Hospital (Taizhou University Hospital)

hozeifa@zju.edu.cn+86 187 5888 7704

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026